Language:

Drug waste minimization as an effective strategy of cost-containment in oncology

BMC health services research, 2014-02, Vol.14 (1), p.57-57, Article 57 [Peer Reviewed Journal]

2014 Fasola et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. ;Copyright © 2014 Fasola et al.; licensee BioMed Central Ltd. 2014 Fasola et al.; licensee BioMed Central Ltd. ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/1472-6963-14-57 ;PMID: 24507545

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Drug waste minimization as an effective strategy of cost-containment in oncology
Author: Fasola, Gianpiero ; Aprile, Giuseppe ; Marini, Luisa ; Follador, Alessandro ; Mansutti, Mauro ; Miscoria, Manuela
Subjects: Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - economics ; Antineoplastic Agents - therapeutic use ; Cancer therapies ; Chemotherapy ; Clinical medicine ; Clinical Protocols ; Cost analysis ; Cost control ; Cost Control - methods ; Drug Costs ; Drug dosages ; Drug stores ; Expenditures ; Humans ; Medical Oncology - economics ; Medical Oncology - methods ; Medical wastes ; Oncology ; Outcome and Process Assessment (Health Care) - methods ; Prescription drugs ; Wage & price controls
Is Part Of: BMC health services research, 2014-02, Vol.14 (1), p.57-57, Article 57
Description: Sustainability of cancer care is a crucial issue for health care systems worldwide, even more during a time of economic recession. Low-cost measures are highly desirable to contain and reduce expenditures without impairing the quality of care. In this paper we aim to demonstrate the efficacy of drug waste minimization in reducing drug-related costs and its importance as a structural measure in health care management. We first recorded intravenous cancer drugs prescription and amount of drug waste at the Oncology Department of Udine, Italy. Than we developed and applied a protocol for drug waste minimization based on per-pathology/per-drug scheduling of chemotherapies and pre-planned rounding of dosages. Before the protocol, drug wastage accounted for 8,3% of the Department annual drug expenditure. Over 70% of these costs were attributable to six drugs (cetuximab, docetaxel, gemcitabine, oxaliplatin, pemetrexed and trastuzumab) that we named 'hot drugs'. Since the protocol introduction, we observed a 45% reduction in the drug waste expenditure. This benefit was confirmed in the following years and drug waste minimazion was able to limit the impact of new pricely drugs on the Department expenditures. Facing current budgetary constraints, the application of a drug waste minimization model is effective in drug cost containment and may produce durable benefits.
Publisher: England: BioMed Central
Language: English
Identifier: ISSN: 1472-6963
EISSN: 1472-6963
DOI: 10.1186/1472-6963-14-57
PMID: 24507545
Source: SpringerOpen
Geneva Foundation Free Medical Journals at publisher websites
MEDLINE
PubMed Central
ROAD: Directory of Open Access Scholarly Resources
ProQuest Central
DOAJ Directory of Open Access Journals

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Drug waste minimization as an effective strategy of cost-containment in oncology

Searching Remote Databases, Please Wait